Abcam Ltd (Abcam) a subsidiary of Danaher Corp, manufactures and supplies life science research tools such as antibodies and associated products that enable analysis of living cells at the molecular level. It develops, manufactures, and markets antibodies; research-grade antibodies; in vitro diagnostic (IVD) antibodies; kits; agonists, antagonists, activators, and inhibitors; and proteins and peptides.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Abcam focuses on developing and innovating products to enhance and expand its range of technologies, enabling in-house new product development and manufacturing at scale. Its focused research and development (R&D) efforts facilitate the development of new antibody products and improve the quality of its existing catalog. The company is focused on high-quality, validated products and supporting scientists. Its product portfolio includes proteins, antibodies, assay kits, and engineered cell lines. The company also focuses on partnering with disease charities, life science organizations, and pharmaceutical and biotechnology companies.